Navigation Links
National Patient Advocate Foundation (NPAF) Statement Regarding New FDA Label on Erythropoietin Stimulating Agents (ESAs)
Date:11/9/2007

WASHINGTON, Nov. 9 /PRNewswire-USNewswire/ -- The non-profit National Patient Advocate Foundation (NPAF), representing the voice of millions of patients assisted nationally in more than a decade through our direct-patient-services affiliate Patient Advocate Foundation (PAF), continues to routinely receive inquiries from patients wanting to know more about the use of Erythropoietin Stimulating Agents (ESA). These patients, with life-threatening, debilitating and chronic conditions, continue to seek information about best-available treatment and payment options from PAF - and we share their concerns and frustrations about the lack of information available on the safe use of ESAs.

We commend the FDA and ESA sponsors for their diligence, especially in recent months, to garner the information that patients and their physicians need to make the best informed decisions about the use of these important therapies.

NPAF believes that both the sponsors and the FDA have the responsibility to demonstrate to the American public that ESA drugs are safe and effective when administered within the recommended guidelines. Despite known and long-term safety concerns about these drugs, so far the evidence needed to clear up the questions of safety remains lacking. Further scientific studies are currently underway, but may take from months to years to complete. NPAF intends to promote the necessary clinical trials, and will participate in a workshop at the National Cancer Institute next month to further define the additional studies needed for ESA drugs.

Due to the urgent need for updated information reaching the public on ESAs, NPAF strongly encourages the FDA and sponsors to create a Medication Guide on ESAs, as discussed recently by Dr. Richard Padzur, director of the FDA Division of Oncology Drug Products.

In summary, FDA has taken the unusual position of raising serious concerns about ESA drugs despite what seems to be a lack of definitive scientif
'/>"/>

SOURCE National Patient Advocate Foundation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... The Case Management Society of ... provide CMSA's Career and Knowledge Pathways educational program ... strengthen the case/care management workforce by offering aptitude ... mutually beneficial agreement provides Medix, a workforce solutions ... in the healthcare, scientific and IT industries, access ...
(Date:5/27/2015)... CompanionDx announced that its ... analysis in personalized cancer therapy: Non-small cell lung cancer ... of Clinical Oncology (ASCO) as part of their annual ... The molecular and clinical data used for the study ... The study reports improved patient outcomes from a preliminary ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 This ... current state of the Omega-3 industry. The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ... Rieber Oils, Camanchaca Fishing Company, Seadragon Marine Oils, ...
(Date:5/27/2015)... “Heroin has never been more plentiful or cheaper, ... from,” says Harford County Sheriff Jeff Gahler, as quoted by ... surging heroin related incidents in Baltimore, police resources are running ... heroin addiction and subsequent abuse before it turns into a ... is a drug and alcohol rehab facility specializing in heroin ...
(Date:5/27/2015)... May 27, 2015 A television program ... MediaSource and Roswell Park Cancer Institute ... The award-winning story, Cancer Can’t Win , highlights ... Park Cancer Institute. The production team followed five people ... months as they received treatment from doctors and medical ...
Breaking Medicine News(10 mins):Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 3
... sharp increase in the number of fat babies; the trend ... the nation’s obesity epidemic//. ,Researchers from the Harvard ... in the July issue of Obesity, have shown a 73.5% ... have said that infants now are 59% more likely to ...
... were many teenagers in Britain who knew as to how ... shown that several of the teens had admitted that they ... off too early. They explained that teenagers with their lack ... the risks of pregnancies and sexually transmitted infections (STI). ...
... Livingston has accused the NHS of giving false information since ... to remove a non-viable fetus. Doctors at the town's St ... womb was dead. ,After this she underwent a procedure ... weeks she found she was still pregnant. "A scan on ...
... of scars following injection with botulinum toxin (BOTOX?) early ... ,The injection prevents muscle movement from wrinkling the wound ... surface for healing and leaving a smoother final scar.,The ... the early healing phase with the injection improves the ...
... School of Medicine have shown the form of a crucial ... to the DNA .The enzyme, which is named, as a ... novel methods to combat small pox. ,"This enzyme ... biology," says Frederic D. Bushman, PhD, Professor of Microbiology, one ...
... a woman from Hamilton was convicted for not informing her doctors ... son// also being infected. ,She was charged for failing ... for child neglect. She was given a 6-month conditional sentence and ... the sentence on 6ht of April but was reported only yesterday ...
Cached Medicine News:Health News:Study finds Babies In America Getting Fatter 2Health News:Teens In UK Do Not Know How To Use A Condom 2Health News:Appearance Of Facial Scars Improved By Botulinum Toxin 2Health News:Appearance Of Facial Scars Improved By Botulinum Toxin 3Health News:Appearance Of Facial Scars Improved By Botulinum Toxin 4Health News:Penn Researchers Throw Light on the Structure Of Smallpox Virus Protein 2
(Date:5/27/2015)...  Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce ... Financial Officer, will present at the Jefferies 2015 Global Healthcare ... New York City . The ... the Cambrex website at www.cambrex.com in the Investors ... available for 90 days after the live event concludes.  ...
(Date:5/27/2015)... , May 27, 2015  Novartis will ... in 21 medicines and 11 investigational compounds across ... American Society of Clinical Oncology (ASCO) Annual Meeting, ... European Hematology Association (EHA), June 11-14. Data will ... cancer types, including melanoma, lung, breast, kidney and ...
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... of the "Research and Future Development Trend Forecast ... offering. At present, there are 35,600 dialysis ... concentration ratio are large due to the different regional ... dialysis centers in other Asian countries are operated by ...
Breaking Medicine Technology:Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 2Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 3Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 4Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 5Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 6Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 7Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 8China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2
... First Stop absorbable collagen hemostat. FirstStop is ... handling and removal characteristics. It can easily ... fit the wound. FirstStop products are not ... peeled away after hemostasis is achieved. As ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
... D-Stat Flowable Hemostat has a thick, ... application, such as vascular access sites ... is also used as an adjunct ... tissue tracts of femoral access sites ...
The D-Stat Radial hemostat band utilizes a compression band together with the active haemostatic material of the D-Stat to control surface bleeding....
Medicine Products: